Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon-alpha therapy in hypernephroma]

K P Sagaster1

  • 1I. Medizinischen Abteilung mit Onkologie, Wilhelminenspitals, Wien.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1993
PubMed
Summary

Metastatic renal cell cancer has a poor prognosis. Interferon (IFN) therapy shows promise, with combinations like IFN-alpha and vinblastine potentially increasing remission rates for this challenging cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Prevalence and potential associations of the 2022 newly introduced monocyte value for diagnosis of chronic myelomonocytic leukemia in a general Austrian population.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A One Health digital twin framework for leprosy: linking host, pathogen, and population dynamics.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

[Changed profile of requirements in pediatric prehospital emergency care-a retrospective analysis of the Karlsruhe pediatric ambulance service].

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Research

Context:

  • Metastatic renal cell cancer (mRCC) presents a significant clinical challenge with limited treatment efficacy.
  • Conventional therapies including chemotherapy, radiation, and hormonal therapy offer poor response rates (≤10%) for mRCC patients.
  • Previous immunotherapy approaches have not substantially improved treatment outcomes.

Purpose:

  • To review the efficacy of interferon (IFN) based therapies in metastatic renal cell cancer.
  • To explore novel treatment combinations and their potential to enhance therapeutic responses.

Summary:

  • Interferon (IFN) therapy has demonstrated improved remission rates (15-40%) in mRCC, influenced by prognostic factors.
  • Combination therapies, such as IFN-alpha with vinblastine, suggest enhanced response rates.
  • Emerging strategies involve combining IFN-alpha with other cytokines like IFN-gamma, interleukin-2, or 5-fluorouracil, indicating greater effectiveness than monotherapy.

Impact:

  • Highlights the potential of interferon-based immunotherapy to improve outcomes for patients with metastatic renal cell cancer.
  • Identifies promising combination therapies that warrant further investigation for mRCC treatment.
  • Suggests new avenues for drug development and clinical trials in advanced kidney cancer.

Related Experiment Videos